B of A Securities analyst Andrew Obin downgrades Johnson Controls Intl (NYSE:JCI) from Buy to Neutral.
Baird Maintains Neutral on Cardinal Health, Raises Price Target to $82
Baird analyst Eric Coldwell maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $74 to $82.